ArchivesMagazine - 23 Sep 2021Alliance Pharma’s growth potential remains underappreciated Company has integrated a new major US brand and strengthened its cross border e-commerce capability in China 23 September 2021|Great Ideas|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Stagecoach founders’ share sale may have triggered takeover move Why this Japanese trust has gained 15% in a month > Issue: 23 Sep 2021 - Page 17 | Contents Next: Why this Japanese trust has gained 15% in a month Previous: Stagecoach founders’ share sale may have triggered takeover move Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom Help, I don’t understand the flexi-access options for pensions Editor's View Gas, shipping, coal: hot themes drive investors wild Feature The new look FTSE 100: How the index might evolve in 2022 and beyond Investing your pension: eight important points to think about Great Ideas A brighter outlook for property makes this 5% yielding trust a bargain Want Asia exposure but worried about China? Try Vietnam China exposure is a key risk for Lindsell Train Equity Fund Close to 50% gain from Equals since April, more to come? Alliance Pharma’s growth potential remains underappreciated Why this Japanese trust has gained 15% in a month Investment Trusts Catch these star turn investment trusts on the way up News Markets see red as list of investor concerns grows AstraZeneca breakthrough makes up for Covid vaccine setback Stagecoach founders’ share sale may have triggered takeover move Shell picks up pace with transition away from oil and gas Personal Finance Going to university? Five ways to get your finances in order Russ Mould Will food prices fuel inflation? Under The Bonnet Dianomi chases big contextual ads opportunity
